These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28207746)

  • 1. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.
    Foliaki ST; Lewis V; Finkelstein DI; Lawson V; Coleman HA; Senesi M; Islam AMT; Chen F; Sarros S; Roberts B; Adlard PA; Collins SJ
    PLoS Pathog; 2018 Aug; 14(8):e1007214. PubMed ID: 30089152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
    Thackray AM; Hopkins L; Bujdoso R
    Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity.
    Shaked GM; Fridlander G; Meiner Z; Taraboulos A; Gabizon R
    J Biol Chem; 1999 Jun; 274(25):17981-6. PubMed ID: 10364247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of thermolysin in the diagnosis of prion diseases.
    Owen JP; Maddison BC; Whitelam GC; Gough KC
    Mol Biotechnol; 2007 Feb; 35(2):161-70. PubMed ID: 17435282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
    D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
    PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmissibility of H-Type Bovine Spongiform Encephalopathy to Hamster PrP Transgenic Mice.
    Okada H; Masujin K; Miyazawa K; Yokoyama T
    PLoS One; 2015; 10(10):e0138977. PubMed ID: 26466381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a proteinase K-sensitive PrPSc fraction.
    Pastrana MA; Sajnani G; Onisko B; Castilla J; Morales R; Soto C; Requena JR
    Biochemistry; 2006 Dec; 45(51):15710-7. PubMed ID: 17176093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
    Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
    J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene.
    Büeler H; Raeber A; Sailer A; Fischer M; Aguzzi A; Weissmann C
    Mol Med; 1994 Nov; 1(1):19-30. PubMed ID: 8790598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.